Cargando…

The Latest Evidence of Erythropoietin in the Treatment of Glaucoma

Erythropoietin (EPO) is a circulating hormone conventionally considered to be responsible for erythropoiesis. In addition to facilitating red blood cell production, EPO has pluripotent potential, such as for cognition improvement, neurogenesis, and anti-fibrotic, anti-apoptotic, anti-oxidative, and...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lin, Ting-Yi, Lai, Yi-Fen, Chen, Yi-Hao, Lu, Da-Wen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9784015/ https://www.ncbi.nlm.nih.gov/pubmed/36555679 http://dx.doi.org/10.3390/ijms232416038

Ejemplares similares

Erythropoietin in Glaucoma: From Mechanism to Therapy
por: Lai, Yi-Fen, et al.
Publicado: (2023)

Erythropoietin in Optic Neuropathies: Current Future Strategies for Optic Nerve Protection and Repair
por: Lai, Yi-Fen, et al.
Publicado: (2022)

Emollient treatment of atopic dermatitis: latest evidence and clinical considerations
por: Hon, Kam Lun, et al.
Publicado: (2018)

Erythropoietin levels in aqueous humor of patients with glaucoma
por: Nassiri, Nader, et al.
Publicado: (2012)

Latest evidence on immunotherapy for cholangiocarcinoma
por: Guo, Xurui, et al.
Publicado: (2020)

The Latest Drugs in Development That Reduce Intraocular Pressure in Ocular Hypertension and Glaucoma
por: Jayanetti, Viran, et al.
Publicado: (2020)

Treatment of diverticular disease: an update on latest evidence and clinical implications
por: Carabotti, Marilia, et al.
Publicado: (2018)

Latest Evidence on Sulfonylureas: What’s New?
por: Leiter, Lawrence A.
Publicado: (2020)

Astrocyte polarization in glaucoma: a new opportunity
por: Liu, Yi-Xin, et al.
Publicado: (2022)

A deep dive into the latest European Glaucoma Society and Asia-Pacific Glaucoma Society guidelines and their relevance to India
por: Murthy, Gowri J, et al.
Publicado: (2022)

Nutrition, dietary interventions and prostate cancer: the latest evidence
por: Lin, Pao-Hwa, et al.
Publicado: (2015)

Outcomes of Small Size Ahmed Glaucoma Valve Implantation in Asian Chronic Angle-Closure Glaucoma
por: Huang, Ke-Hao, et al.
Publicado: (2021)

New developments in ulcerative colitis: latest evidence on management, treatment, and maintenance
por: Tripathi, Kartikeya, et al.
Publicado: (2019)

Durvalumab in NSCLC: latest evidence and clinical potential
por: Muñoz-Unceta, Nerea, et al.
Publicado: (2018)

Latest Evidence on Post-Prostatectomy Urinary Incontinence
por: Gacci, Mauro, et al.
Publicado: (2023)

Latest SARS evidence
por: Walgate, Robert
Publicado: (2003)

Latest Developments in Normal-Pressure Glaucoma: Diagnosis, Epidemiology, Genetics, Etiology, Causes and Mechanisms to Management
por: Lee, Jacky W.Y., et al.
Publicado: (2019)

Treatment of advanced, metastatic soft tissue sarcoma: latest evidence and clinical considerations
por: In, Gino K., et al.
Publicado: (2017)

Orodispersible budesonide tablets for the treatment of eosinophilic esophagitis: a review of the latest evidence
por: Miehlke, Stephan, et al.
Publicado: (2020)

Erythropoietin Protects Adult Retinal Ganglion Cells against NMDA-, Trophic Factor Withdrawal-, and TNF-α-Induced Damage
por: Chang, Zhi-Yang, et al.
Publicado: (2013)

The latest evidence for possible HIV-1 curative strategies
por: Pham, Hanh Thi, et al.
Publicado: (2018)

Regorafenib in hepatocellular carcinoma: latest evidence and clinical implications
por: Personeni, Nicola, et al.
Publicado: (2018)

Pembrolizumab in cervical cancer: latest evidence and clinical usefulness
por: Borcoman, Edith, et al.
Publicado: (2017)

Fundamental concepts and the latest evidence for esophageal pressure monitoring
por: Shimatani, Tatsutoshi, et al.
Publicado: (2023)

Latest updates on the serotonergic system in depression and anxiety
por: Lin, Jianwen, et al.
Publicado: (2023)

Transforming growth factor-β1 decreases erythropoietin production through repressing hypoxia-inducible factor 2α in erythropoietin-producing cells
por: Shih, Hong-Mou, et al.
Publicado: (2021)

Tildrakizumab in the treatment of psoriasis: latest evidence and place in therapy
por: Pithadia, Deeti J., et al.
Publicado: (2019)

Erythropoietin and the use of a transgenic model of erythropoietin-deficient mice
por: Pichon, Aurélien, et al.
Publicado: (2016)

Sumatriptan-induced angle-closure glaucoma: A case report
por: Hsu, Cherng-Ru, et al.
Publicado: (2017)

Latest Innovations in the Treatment of Venous Disease
por: Attaran, Robert R.
Publicado: (2018)

Treatment of Anemia in Kidney Disease: Beyond Erythropoietin
por: Wish, Jay B.
Publicado: (2021)

Vitamin D and Breast Cancer: Latest Evidence and Future Steps
por: Atoum, Manar, et al.
Publicado: (2017)

Targeted therapy of brain metastases: latest evidence and clinical implications
por: Di Lorenzo, Rodica, et al.
Publicado: (2017)

Adding ezetimibe to statin therapy: latest evidence and clinical implications
por: Vavlukis, Marija, et al.
Publicado: (2018)

Managing hyponatremia in lung cancer: latest evidence and clinical implications
por: Fiordoliva, Ilaria, et al.
Publicado: (2017)

Treating KRAS-mutant NSCLC: latest evidence and clinical consequences
por: Garrido, Pilar, et al.
Publicado: (2017)

Sustained remission in rheumatoid arthritis: latest evidence and clinical considerations
por: Ajeganova, Sofia, et al.
Publicado: (2017)

Early Ahmed Glaucoma Valve Implantation after Penetrating Keratoplasty Leads to Better Outcomes in an Asian Population with Preexisting Glaucoma
por: Tai, Ming-Cheng, et al.
Publicado: (2012)

Renal Denervation for Resistant Hypertension: A Concise Update on Treatment Options and the Latest Clinical Evidence
por: Fengler, Karl
Publicado: (2022)

Precision Approaches in the Management of Colorectal Cancer: Current Evidence and Latest Advancements towards Individualizing the Treatment
por: Shuford, Rebecca A., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_ls9atpv5oa0e0naa8fv3cd4h26